Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, October 19, 2017

PPI use linked to increased risk of ischemic stroke, MI

For those who know what this means, be careful out there.
https://medicalxpress.com/news/2017-10-ppi-linked-ischemic-mi.html

Thomas S.G. Sehested, M.D., from The Danish Heart Foundation, and colleagues identified all Danish individuals with no prior history of MI or who had elective performed between 1997 and 2012. The authors examined the correlation between current PPI use/dose and the risk of first-time ischemic stroke and MI.
The researchers identified 7,916 and 5,608 MIs among 214,998 individuals during a median follow-up of 5.8 years. After adjustment for age, sex, comorbidities, and concomitant medications, the rates of ischemic stroke and MI were significantly increased with current PPI exposure (hazard ratios, 1.13 and 1.31). High-dose PPI was correlated with elevated rates of ischemic stroke and MI (hazard ratios, 1.31 and 1.43, respectively). There was no significant correlation for histamine H2 receptor antagonist use with ischemic stroke or MI. Compared with non-users, long-term PPI users had 29 and 36 percent greater absolute risks of ischemic stroke and MI, respectively, within a six-month period.
"Use of PPIs was associated with increased risks of first -time ischemic stroke and MI, particularly among long -term users and at high doses," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Explore further: Greater benefit for pioglitazone in high-risk patients post stroke
More information: Abstract
Full Text (subscription or payment may be required)

Journal reference: Journal of Internal Medicine search and more info website
Posted by at
Labels: , , , ,

1 comment:

  1. Rebecca DuttonOctober 20, 2017 at 9:23 AM

    I was able to read this post calmly because I stopped taking a PPI that is associated bone loss and went back to taking a histamine h-2 drug for acid reflux (Zantac).

    ReplyDelete

Subscribe to: Post Comments (Atom)